Back

Serelaxin.

29 April 2017 (14:45 - 15:03)
Organised by:
Congress Presentation Part of: Novel drugs in acute heart failure: hurdles, hype and hope Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Marco Metra

IRCCS San Raffaele Scientific Institute, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
HNO Donors.
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Omecamtiv mecarbil
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Elamipretide.
Professor H. Sabbah (Detroit, US)
Slides Video
Presentation thumbnail
Vericiquat.
Professor B. Pieske (Rostock, DE)
Slides Video

Access the full session

Session thumbnail
Novel drugs in acute heart failure: hurdles, hype and hope

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 14:45 CET
You may be interested in
thumbnail
Congress Presentation
Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor
20 May 2023
thumbnail
Congress Presentation
Milrinone, dobutamine or levosimendan as first line inotrope in cardiogenic shock?
26 March 2023
thumbnail
Congress Presentation
Assessment of cardiac reverse remodeling in patients with LV systolic dysfunction receiving vericiguat in addition to optimal GDMT
13 December 2024
thumbnail
Congress Presentation
The ghrelin receptor agonist AC01 improves cardiac function in non-human primates and in mice with heart failure by increasing cardiomyocyte contractility
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources